Cancer

News

Sandoz strikes deal with EirGenix for Herceptin biosimilar

Sandoz has struck a deal with Taiwan-based EirGenix to market a late-stage biosimilar of Roche’s breast cancer blockbuster Herceptin.

News

Sanofi/Regeneron skin cancer drug among flurry of decisions ...

A new drug for advanced skin cancer and a long-lasting treatment for haemophilia A are among a group of new drugs that look set for the European market following backing from regulators.

News

AstraZeneca revival continues as new cancer drugs gallop ahe...

AstraZeneca’s revival has continued with a third successive quarter of growth, as sales of new drugs for cancer and lung diseases outperformed the market’s expectations.

News

Many patients still denied cancer drugs in UK, survey finds

The Institute for Cancer Research has called for action to improve access to innovative cancer treatments after a new survey found that many UK patients are being denied drugs and see the p

News

Psoriasis and cardio drugs drive Novartis' Q1 sales

Novartis has begun 2019 at a sprint, upgrading its sales forecasts for the year after strong performances from psoriasis drug Cosentyx and cardiology medicine Entresto.

Views & Analysis

Organoids: bringing life to precision medicine

Swiss-based biotech QGel is hoping to offer a novel approach to precision medicine by solving several of the current challenges with ‘organoids’, which can be used to test medicines on orga

Sandoz strikes deal with EirGenix for Herceptin biosimilar

Sanofi/Regeneron skin cancer drug among flurry of decisions ...

AstraZeneca revival continues as new cancer drugs gallop ahe...

Many patients still denied cancer drugs in UK, survey finds

Psoriasis and cardio drugs drive Novartis' Q1 sales

Organoids: bringing life to precision medicine

AI specialists Enveda and Basecamp rake in the cash

Discover a new era of healthcare panel engagement: Grounded ...

Cancer

Editor's Picks